Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  BOARD MEETINGS
Board Meetings      
Sanofi India Ltd.
Source DateBoard Meeting DateDetails
17-Oct-2024 07-Nov-2024 Quarterly Results
08-Jul-2024 26-Jul-2024 Quarterly Results
26-Apr-2024 13-May-2024 Quarterly Results
24-Jan-2024 23-Feb-2024 Dividend & Audited Results
19-Oct-2023 08-Nov-2023 Quarterly Results
26-Jul-2023 10-Aug-2023 Quarterly Results
11-Apr-2023 10-May-2023 Quarterly Results
07-Feb-2023 23-Feb-2023 Dividend & Audited Results
21-Oct-2022 03-Nov-2022 Quarterly Results
06-Jul-2022 26-Jul-2022 Quarterly Results & Interim Dividend
07-Apr-2022 26-Apr-2022 Quarterly Results
07-Feb-2022 23-Feb-2022 Final Dividend & Audited Results
13-Oct-2021 26-Oct-2021 Quarterly Results
12-Jul-2021 27-Jul-2021 Quarterly Results
15-Apr-2021 27-Apr-2021 Quarterly Results
08-Feb-2021 23-Feb-2021 Final Dividend & Audited Results
13-Oct-2020 27-Oct-2020 Quarterly Results
15-Jul-2020 28-Jul-2020 Quarterly Results
12-May-2020 19-May-2020 Quarterly Results
25-Feb-2020 25-Feb-2020 Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2020, inter alia, has considered and approved the following : 1. Recommendation for payment of final dividend of Rs. 106 per equity share Rs. 10 each and one-time special dividend of Rs. 243 per equity share Rs. 10 each for the year ended December 31, 2019. The total dividend recommended is Rs. 349 per equity share Rs. 10 each for the year ended December 31, 2019. 2. The final as well as one-time special dividend, if approved by the shareholders will be paid on or after May 05, 2020.
Page 1 of 5
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.